An update on the role of bariatric surgery in diabetes management

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 2, 2015, Pages 98-105

  Malkani, Samir ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

bariatric surgery; diabetes remission; glucose metabolism; gut hormones; obesity

Indexed keywords

GASTROINTESTINAL HORMONE;

BARIATRIC SURGERY; BODY MASS; CALORIC RESTRICTION; DIABETES CONTROL; DIABETES MELLITUS; GASTRIC BANDING; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RELAPSE; REMISSION; REVIEW; SAFETY; SLEEVE GASTRECTOMY; STOMACH BYPASS; WEIGHT REDUCTION; ADVERSE EFFECTS; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; METABOLISM; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME;

BARIATRIC SURGERY; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GASTROINTESTINAL HORMONES; HUMANS; OBESITY; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84926362094     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000143     Document Type: Review

References (50)

1. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ 2014; 349:g3961.
2. Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369:145-154.
3. Reames BN, Finks JF, Bacal D, et al. Changes in bariatric surgery procedure use in Michigan, 2006-2013. J Am Med Assoc 2014; 312:959-961.
4. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev 2014; 8:CD003641.
5. Dogan K, Gadiot RP, Aarts EO, et al. Effectiveness and safety of sleeve gastrectomy, gastric bypass, and adjustable gastric banding in morbidly obese patients: a multicenter, retrospective, matched cohort study. Obes Surg 2014; doi: 10.1007/s11695-014-1503-8. [Epub ahead of print]
6. Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361:445-454.
7. Puzziferri N, Roshek TB 3rd, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. J Am Med Assoc 2014; 312:934-942.
8. Maciejewski ML, Livingston EH, Smith VA, et al. Survival among high-risk patients after bariatric surgery. J Am Med Assoc 2011; 305:2419-2426.
9. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes. N Engl J Med 2014; 370:2002-2013.
10. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366:1567-1576.
11. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. J Am Med Assoc 2013; 309:2240-2249.
12. Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 2014; 149:707-715.
13. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577-1585.
14. Liang Z, WuQ, Chen B, et al. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 2013; 101:50-56.
15. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. J Am Med Assoc 2013; 309:2250-2261.
16. Parikh M, Issa R, Vieira D, et al. Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH criteria: a systematic review and meta-analysis. J Am Coll Surg 2013; 217:527-532.
17. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Inter Med 2013; 273:219-234.
18. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357:753-761.
19. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. J Am Med Assoc 2012; 308:1122-1131.
20. Scott WR, Batterham RL. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 2011; 301:R15-R27.
21. Samat A, Malin SK, Huang H, et al. Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab 2013; 15:963-966.
22. Chronaiou A, Tsoli M, Kehagias I, et al. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. Obes Surg 2012; 22:1761-1770.
23. Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in nondiabetic humans. Obes Surg 2014; 24:241-252.
24. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 2013; 98:4391-4399.
25. Kamvissi V, Salerno A, Bornstein SR, et al. Incretins or anti-incretins? A new model for the entero-pancreatic axis. Hormone Metab Res 2015; 47:84-87.
26. Sala PC, Torrinhas RS, Giannella-Neto D, Waitzberg DL. Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metab Syndrome 2014; 6:87.
27. Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2014; 63:1725-1737.
28. Salehi M, Prigeon RL, DAlessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011; 60:2308-2314.
29. Umeda LM, Silva EA, Carneiro G, et al. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients. Obes Surg 2011; 21:896-901.
30. Lindqvist A, Spegel P, Ekelund M, et al. Effects of ingestion routes on hormonal and metabolic profiles in gastric-bypassed humans. J Clin Endocrinol Metab 2013; 98:E856-E861.
31. Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014; 63:1214-1223.
32. Lingvay I, Guth E, Islam A, Livingston E. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes care 2013; 36:2741-2747.
33. Goldfine AB, Patti ME. Diabetes improvement following Roux-en-Y gastric bypass: understanding dynamic changes in insulin secretion and action. Diabetes 2014; 63:1454-1456.
34. Kim M, Son YG, Kang YN, et al. Changes in glucose transporters, gluconeogenesis, and circadian clock after duodenal-jejunal bypass surgery. Obes Surg 2014; doi: 10.1007/s11695-014-1434-4. [Epub ahead of print]
35. Browning KN, Fortna SR, Hajnal A. Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol 2013; 591:2357-2372.
36. Ikramuddin S, Blackstone RP, Brancatisano A, et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. J Am Med Assoc 2014; 312:915-922.
37. Kassam Z, Smith M, Alm E. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med 2014; 371:680.
38. Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 2013; 98:16-24.
39. Werling M, Vincent RP, Cross GF, et al. Enhanced fasting and postprandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol 2013; 48:1257-1264.
40. Khoo CM, Muehlbauer MJ, Stevens RD, et al. Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction. Ann Surg 2014; 259:687-693.
41. English TM, Malkani S, Kinney RL, et al. Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control. Obes Surg 2015; 25:1-6.
42. Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol 2014; 2:38-45.
43. Robert M, Ferrand-Gaillard C, Disse E, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg 2013; 23:770-775.
44. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013; 23:93-102.
45. Malin SK, Bena J, Abood B, et al. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes nonremission status after bariatric surgery. Diabetes Obes Metab 2014; 16:1230-1238.
46. Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. J Am Med Assoc 2013; 310:2416-2425.
47. Wolfe BM, Purnell JQ, Belle SH. Treating diabetes with surgery. J Am Med Assoc 2013; 309:2274-2275.
48. Wolfe BM, Belle SH. Long-term risks and benefits of bariatric surgery: a research challenge. J Am Med Assoc 2014; 312:1792-1793.
49. Arterburn DE, Fisher DP. The current state of the evidence for bariatric surgery. J Am Med Assoc 2014; 312:898-899.
50. Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health Symposium. JAMA Surg 2014; 149:1323-1329.